Skip to main content
Caplight Logo









iosBio

iosBio

Private
Haywards HeathHealthcare & Life Scienceshttps://iosbio.com/

Last Round

Series A

May 1, 2025

Total Funding Raised

$390,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

iosBio is a biotechnology company that develops thermostable, orally delivered vaccines for major infectious diseases using its proprietary OraPro™ and Enhanced Surface Display (ESD™) technology platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

oral vaccinethermostable vaccineneedle-free deliveryself-administered vaccinecold-chain freeviral vectormucosal immunityantigen designbiotech licensingpill vaccinevaccine platformcomputational biologyin-silico design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iosBio Comparables

Compare iosBio with similar companies based on industry and business-model similarity.

iosBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GIVAX
78%
Vaxart, Inc.
78%
Esperovax
76%

iosBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2025
GrantFeb 23, 2022
VC RoundMay 12, 2020
VC RoundMar 18, 2009

iosBio Investors

Notable investors and investment history

iosBio investors
InvestorRounds
Shackleton VenturesVC Round
Department of Health and Social CareGrant
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 122% MoM.

  • Jul 25, 2026

    Monthly visitors increased 116% MoM.

iosBio Filings

Explore SEC and related filing metadata, where available.

iosBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about iosBio's valuation, stock price, and market status.

Is iosBio a public or private company?

iosBio is a private company.

What is the current stock price of iosBio?

iosBio is a private company with no public stock price. No recent secondary market data is available.

How much is iosBio worth (valuation)?

Valuation information for iosBio is not publicly available.

Can I buy iosBio stock?

iosBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was iosBio's last funding round?

iosBio's most recent funding round was Series B on May 1, 2025.

Who are the main investors in iosBio?

Investor information for iosBio is not publicly disclosed.

Will iosBio IPO soon?

No public IPO plans have been announced for iosBio.

How can I track iosBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iosBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHaywards Heath
Employee Range12
Year Founded2002
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?